Literature DB >> 26055136

Postoperative Mortality Among Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis of Population-Based Studies.

Sunny Singh1, Ahmed Al-Darmaki1, Alexandra D Frolkis2, Cynthia H Seow3, Yvette Leung3, Kerri L Novak3, Subrata Ghosh3, Bertus Eksteen3, Remo Panaccione3, Gilaad G Kaplan4.   

Abstract

BACKGROUND & AIMS: There have been varying reports of mortality after intestinal resection for the inflammatory bowel diseases (IBDs). We performed a systematic review and meta-analysis of population-based studies to determine postoperative mortality after intestinal resection in patients with IBD.
METHODS: We searched Medline, EMBASE, and PubMed, from 1990 through 2015, to identify 18 articles and 3 abstracts reporting postoperative mortality among patients with IBD. The studies included 67,057 patients with ulcerative colitis (UC) and 75,971 patients with Crohn's disease (CD), from 15 countries. Mortality estimates stratified by emergent and elective surgeries were pooled separately for CD and UC using a random-effects model. To assess changes over time, the start year of the study was included as a continuous variable in a meta-regression model.
RESULTS: In patients with UC, postoperative mortality was significantly lower among patients who underwent elective (0.7%; 95% confidence interval [CI], 0.6%-0.9%) vs emergent surgery (5.3%; 95% CI, 3.8%-7.4%). In patients with CD, postoperative mortality was significantly lower among patients who underwent elective (0.6%; 95% CI, 0.2%-1.7%) vs emergent surgery (3.6%; 95% CI, 1.8%-6.9%). Postoperative mortality did not differ for elective (P = .78) or emergent (P = .31) surgeries when patients with UC were compared with patients with CD. Postoperative mortality decreased significantly over time for patients with CD (P < .05) but not UC (P = .21).
CONCLUSIONS: Based on a systematic review and meta-analysis, postoperative mortality was high after emergent, but not elective, intestinal resection in patients with UC or CD. Optimization of management strategies and more effective therapies are necessary to avoid emergent surgeries.
Copyright © 2015 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Complication; Death; Survival; Treatment

Mesh:

Year:  2015        PMID: 26055136     DOI: 10.1053/j.gastro.2015.06.001

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  42 in total

Review 1.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

2.  Going Third Class: Treatment of Steroid-Dependent Ulcerative Colitis.

Authors:  Helen Lee; Yecheskel Schneider; Gary R Lichtenstein
Journal:  Dig Dis Sci       Date:  2019-05       Impact factor: 3.199

3.  Immunosuppressed Patients with Crohn's Disease Are at Increased Risk of Postoperative Complications: Results from the ACS-NSQIP Database.

Authors:  Maria Abou Khalil; Jad Abou-Khalil; Jennifer Motter; Carol-Ann Vasilevsky; Nancy Morin; Gabriela Ghitulescu; Marylise Boutros
Journal:  J Gastrointest Surg       Date:  2019-03-18       Impact factor: 3.452

4.  Smoking Cessation for Crohn's Disease: Clearing the Haze.

Authors:  Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2016-03       Impact factor: 10.864

5.  Natural History of Adult Ulcerative Colitis in Population-based Cohorts: A Systematic Review.

Authors:  Mathurin Fumery; Siddharth Singh; Parambir S Dulai; Corinne Gower-Rousseau; Laurent Peyrin-Biroulet; William J Sandborn
Journal:  Clin Gastroenterol Hepatol       Date:  2017-06-16       Impact factor: 11.382

6.  Mortality Is Rare Following Elective and Non-elective Surgery for Ulcerative Colitis, but Mild Postoperative Complications Are Common.

Authors:  Joseph D Feuerstein; Thomas Curran; Michael Alosilla; Thomas Cataldo; Kenneth R Falchuk; Vitaliy Poylin
Journal:  Dig Dis Sci       Date:  2018-01-20       Impact factor: 3.199

7.  Systematic Review and Meta-analysis: Optimal Salvage Therapy in Acute Severe Ulcerative Colitis.

Authors:  Matthew C Choy; Dean Seah; David M Faleck; Shailja C Shah; Che-Yung Chao; Yoon-Kyo An; Graham Radford-Smith; Talat Bessissow; Marla C Dubinsky; Alexander C Ford; Leonid Churilov; Neville D Yeomans; Peter P De Cruz
Journal:  Inflamm Bowel Dis       Date:  2019-06-18       Impact factor: 5.325

8.  Ulcerative Colitis Patients With Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study.

Authors:  María E Negrón; Ali Rezaie; Herman W Barkema; Kevin Rioux; Jeroen De Buck; Sylvia Checkley; Paul L Beck; Matthew Carroll; Richard N Fedorak; Levinus Dieleman; Remo Panaccione; Subrata Ghosh; Gilaad G Kaplan
Journal:  Am J Gastroenterol       Date:  2016-04-19       Impact factor: 10.864

Review 9.  Acute severe ulcerative colitis: latest evidence and therapeutic implications.

Authors:  Parambir S Dulai; Vipul Jairath
Journal:  Ther Adv Chronic Dis       Date:  2017-11-24       Impact factor: 5.091

10.  AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.

Authors:  Siddharth Singh; Jessica R Allegretti; Shazia Mehmood Siddique; Jonathan P Terdiman
Journal:  Gastroenterology       Date:  2020-01-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.